Albrecht J - Search Results

1

Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.

Davis GL, Wong JB, McHutchison JG, Manns MP, Harvey J, Albrecht J. Davis GL, et al. Among authors: albrecht j. Hepatology. 2003 Sep;38(3):645-52. doi: 10.1053/jhep.2003.50364. Hepatology. 2003. PMID: 12939591

2

Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.

Poynard T, Ratziu V, McHutchison J, Manns M, Goodman Z, Zeuzem S, Younossi Z, Albrecht J. Poynard T, et al. Among authors: albrecht j. Hepatology. 2003 Jul;38(1):75-85. doi: 10.1053/jhep.2003.50267. Hepatology. 2003. PMID: 12829989 Clinical Trial.

3

Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin.

Poynard T, McHutchison J, Manns M, Myers RP, Albrecht J. Poynard T, et al. Among authors: albrecht j. Hepatology. 2003 Aug;38(2):481-92. doi: 10.1053/jhep.2003.50319. Hepatology. 2003. PMID: 12883493 Clinical Trial.

4

Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3.

Zeuzem S, Hultcrantz R, Bourliere M, Goeser T, Marcellin P, Sanchez-Tapias J, Sarrazin C, Harvey J, Brass C, Albrecht J. Zeuzem S, et al. Among authors: albrecht j. J Hepatol. 2004 Jun;40(6):993-9. doi: 10.1016/j.jhep.2004.02.007. J Hepatol. 2004. PMID: 15158341 Clinical Trial.

5

Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin.

McHutchison JG, Poynard T, Esteban-Mur R, Davis GL, Goodman ZD, Harvey J, Ling MH, Garaud JJ, Albrecht JK, Patel K, Dienstag JL, Morgan T; International Hepatitis Interventional Therapy Group. McHutchison JG, et al. Among authors: albrecht jk. Hepatology. 2002 Mar;35(3):688-93. doi: 10.1053/jhep.2002.31870. Hepatology. 2002. PMID: 11870385

6

Economic and clinical effects of evaluating rapid viral response to peginterferon alfa-2b plus ribavirin for the initial treatment of chronic hepatitis C.

Wong JB, Davis GL, McHutchison JG, Manns MP, Albrecht JK; International Hepatitis Interventional Therapy Group. Wong JB, et al. Am J Gastroenterol. 2003 Nov;98(11):2354-62. doi: 10.1111/j.1572-0241.2003.t01-1-08735.x. Am J Gastroenterol. 2003. PMID: 14638334 Clinical Trial.

7

Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy.

Harrison SA, Rossaro L, Hu KQ, Patel K, Tillmann H, Dhaliwal S, Torres DM, Koury K, Goteti VS, Noviello S, Brass CA, Albrecht JK, McHutchison JG, Sulkowski MS. Harrison SA, et al. Hepatology. 2010 Sep;52(3):864-74. doi: 10.1002/hep.23787. Hepatology. 2010. PMID: 20568303 Clinical Trial.

8

Racial differences in hepatitis C treatment eligibility.

Melia MT, Muir AJ, McCone J, Shiffman ML, King JW, Herrine SK, Galler GW, Bloomer JR, Nunes FA, Brown KA, Mullen KD, Ravendhran N, Ghalib RH, Boparai N, Jiang R, Noviello S, Brass CA, Albrecht JK, McHutchison JG, Sulkowski MS; IDEAL Study Team. Melia MT, et al. Among authors: albrecht jk. Hepatology. 2011 Jul;54(1):70-8. doi: 10.1002/hep.24358. Hepatology. 2011. PMID: 21488082 Free PMC article.

9

Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial.

Sulkowski MS, Poordad F, Manns MP, Bronowicki JP, Rajender Reddy K, Harrison SA, Afdhal NH, Sings HL, Pedicone LD, Koury KJ, Sniukiene V, Burroughs MH, Albrecht JK, Brass CA, Jacobson IM; SPRINT-2 Trial Investigators. Sulkowski MS, et al. Among authors: albrecht jk. Hepatology. 2013 Mar;57(3):974-84. doi: 10.1002/hep.26096. Epub 2013 Feb 11. Hepatology. 2013. PMID: 23081753 Clinical Trial.

10

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

Poynard T, McHutchison J, Manns M, Trepo C, Lindsay K, Goodman Z, Ling MH, Albrecht J. Poynard T, et al. Among authors: albrecht j. Gastroenterology. 2002 May;122(5):1303-13. doi: 10.1053/gast.2002.33023. Gastroenterology. 2002. PMID: 11984517

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,247 results

Search Page

Filters